LAVA Therapeutics NV (LVTX) — Capital Reinvestment Ratio
Latest as of December 2022:
0.01x
LAVA Therapeutics NV (LVTX) has a Capital Reinvestment Ratio of 0.01x as of December 2022, meaning it reinvests 0% of its operating cash flow ($35.73 Million) in capital expenditures ($265.00K). See cash generation quality of LAVA Therapeutics NV to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
$35.73 Million
USD
Capital Expenditures
$265.00K
USD
Data as of
Dec 2022
Most recent filing
LAVA Therapeutics NV Capital Reinvestment Ratio (2022–2022)
This chart tracks LAVA Therapeutics NV's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for LAVA Therapeutics NV (2022–2022)
Year-by-year Capital Reinvestment Ratio for LAVA Therapeutics NV from 2022 to 2022. For live market cap and broader valuation context, see market cap of LAVA Therapeutics NV.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.15x | $4.04 Million | $587.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow